专利号:US-8017776-B2 优先权日:2003-07-15 标题 :Methods for synthesis of acyloxyalkyl compounds 发明人:BHAT LAXMINARAYAN; GALLOP MARK A 权利人:XENOPORT INC 摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.
专利号:US-8143437-B2 优先权日:2002-02-19 标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof 发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X 权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC 摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.
专利号:US-7667056-B2 优先权日:2002-08-02 标 题 :Process and new intermediates for the preparation of steroids with a progestogen activity 发明人:GRISENTI PARIDE; PECORA FABIO; VERZA ELISA; LEONI MASSIMO; BOSSI LAURA 权利人:POLI IND CHIMICA SPA 摘要:The present invention relates to a new process of synthesis and to some new intermediates for the preparation of steroids with progestogen activity, more particularly, for the preparation of Desogestrel of formula (I). Said process is characterized by the regioselective reduction of the compound of formula (II) to give the intermediate of formula (III).
专利号:US-6225298-B1 优先权日:1994-11-22 标 题 :Compositions and methods for contraception and for treatment of benign gynecological disorders 发明人:SPICER DARCY V; PIKE MALCOLM CECIL; DANIELS JOHN R 权利人:BALANCE PHARMACEUTICALS INC 摘要:Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
专利号:US-2005239725-A1 优先权日:2002-02-19 标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
专利号:US-2001016578-A1 优先权日:1997-06-18 标 题 :Compositions and methods for contraception and for treatment of benign gynecological disorders 发明人:SPICER DARCY V; PIKE MALCOLM CECIL; DANIELS JOHN R 权利人:BALANCE PHARMACEUTICALS INC 摘要:Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
1: Zafar S, Yousuf S, Kayani HA, Saifullah, Khan S, Al-Majid AM, Choudhary MI. Biotransformation of oral contraceptive ethynodiol diacetate with microbial and plant cell cultures. Chem Cent J. 2012 Sep 29;6(1):109. doi: 10.1186/1752-153X-6-109. 2: Siddique YH, Ara G, Beg T, Afzal M. Protective role of nordihydroguaiaretic acid (NDGA) against the genotoxic damage induced by ethynodiol diacetate in human lymphocytes in vitro. J Environ Biol. 2007 Apr;28(2):279-82. Hungarian. Japanese.
合成参考文献
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198 摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664 参考文献:10.1210/jcem-29-6-807 摘要:BECK P, WELLS SA. Comparison of the Mechanisms Underlying Carbohydrate Intolerance in Subclinical Diabetic Women During Pregnancy and During Post-partum Oral Contraceptive Steroid Treatment1. The Journal of Clinical Endocrinology & Metabolism. 1969 Jun;29(6):807–18. doi: 10.1210/jcem-29-6-807. 参考文献:10.1016/j.arth.2007.11.009|10.1016/j.arth.2007.12.006 摘要:Hernandez-Vaquero D, Fernandez-Carreira JM, Garcia-Sandoval MA. "A randomized clinical trial of cementless femoral stems with and without hydroxyapatite/tricalcium-phosphate coating: an 8- to 12-year follow-up study" by Yoon et al. J Arthroplasty. 2008 Apr;23(3):486–7; author reply 487. doi: 10.1016/j.arth.2007.11.009.